CARDIOVASCULAR JOURNAL OF AFRICA: VOLUME 14, ISSUE 5, SEP 2003
  1. Title: The human immunodeficiency virus and cardiac disease : editorial
    Authors: Makotoko, M.
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.221-223
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 221 The human immunodeficiency virus pandemic has now reached proportions unimaginable 22 years ago when the first AIDS cases were reported in Los Angeles.1 At the end of 2002, UNAIDS reported 42 million adults and children to be living with HIV / AIDS worldwide. Disturbingly, the greatest burden of the disease is on sub-Saharan Africa where 70% (29.4 million) of the affected people live.2 The consequences of this pandemic are devastating and face the ordinary South African daily: chronic illness and disability with loss of income for those lucky enough to have a job, abject poverty, and death, leaving.
     
  2. Title: The cardiovascular consequences of HIV and antiretroviral therapy : cardiovascular topics
    Authors: Venter, W.D.F.; Sanne, I.M.
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.225-229
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Antiretroviral therapy has changed the face of the treatment of HIV throughout the world, converting a fatal into a chronic disease. HIV has reached disastrous levels of infection in southern Africa, and increased use of lifesaving therapy is being implemented. The antiretrovirals have a variety of metabolic side effects that have been implicated in cardiovascular disease in other populations. This article discusses the impact of HIV on southern Africa, the metabolic and cardiac complications of both HIV and antiretrovirals, and strategies for dealing with drug side effects.
     
  3. Title: The William Nelson ECG quiz
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.229, 237
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... The William Nelson ECG Quiz The answer is provided on page 237. This is the ECG of a 65-year-old woman. 'My heart beats funny'. Looking closely, it is evident that the 'atrial challenge rate' is approximately 215/min (arrows). Many P waves are buried, but measuring carefully, the P-P cycle is regular. The AV conduction is variable with some stimuli blocked 'high' and the alternating ones conducted with prolonging P-R intervals (Wenckebach block). Of interest, when the Wenckebach 'drop beat' occurs, the previously non-conducted P wave achieves transmission. Dr Alan Lindsay called this the 'leapfrog phenomenon'. This was a single ECG ..
     
  4. Title: Cardiac involvement in HIV-infected people living in Africa : a review : review article
    Authors: Magula, Nombulelo P.; Mayosi, Bongani M.
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.231-237
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: The primary objective of this study was to review and summarise the literature on the spectrum and management of cardiac disease in HIV-infected people living in Africa. We searched MEDLINE (January 1980 to February 2003), reference lists of papers, and reviews on the subject, and contacted experts working in the field for information on relevant references. The review was limited to papers that were published in peer-reviewed journals and indexed on MEDLINE. Seventeen of the 21 studies identified met the inclusion criteria for analysis.
    The studies confirmed that cardiac abnormalities are more common in HIV-infected people, compared to normal controls, and that about half of hospitalised patients and a significant proportion of patients followed up over several years develop cardiac abnormalities. The commonest HIV-related cardiac abnormalities were cardiomyopathy and pericardial disease. Tuberculosis was the major cause of large pericardial effusion in Africa. Myocarditis was the commonest pathological abnormality in HIV-associated cardiomyopathy, and non-viral opportunistic infections such as toxoplasmosis and cryptococcosis may account for up to 50% of cases of HIV-associated cardiomyopathy in Africa.
    Echocardiography is indicated in HIV-positive patients with cardiac symptoms or signs. If cardiomyopathy or pericardial disease is identified, further investigation must be considered to exclude potentially treatable opportunistic infections. Further research in large numbers of patients is needed to determine the value of endomyocardial biopsy in the management of patients with HIV-associated cardiomyopathy, and to establish the place of adjuvant steroids in the treatment of HIV-associated tuberculous pericarditis.
     
  5. Title: SA Heart Association Congress, Cape Town International Convention Centre, 24 - 28 October 2003 : Heart failure : prevention, control and repair : programme and abstracts
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.241-274
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... SA HEART 2003 CONFERENCE CAPE TOWN INTERNATIONAL CONVENTION CENTRE http://www.saheart.org HEART FAILURE: PREVENTION, CONTROL AND REPAIR 24 - 28 OCTOBER 2003 Welcome to the South African Heart Association Congress 2003 Various interest groups, societies and individuals involved in cardiovascular healthcare and research have contributed towards putting together the programme for this meeting - the South African Heart Association, the Lipid Association of South Africa, the South African Paediatric Cardiology Association, the Cardiac Arrhythmia Association of South Africa, the South African Society for Cardiac Intervention (SASCI), Perfmed, Dr Dave Harris (cardiothoracic surgery programme) and Dr Jos du Toit (basic science programme).This collaboration ..
     
  6. Title: Perindopril (Coversyl(R)) prevents cardiovascular death and MI in coronary disease patients regardless of their cardiovascular risk : drug trends in cardiology
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.277-279
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 277 Perindopril* (Coversyl(r)) prevents cardiovascular death and MI in coronary disease patients regardless of their cardiovascular risk The long-acting ACE inhibitor perindopril (Coversyl(r)) significantly reduces the risk of cardiovascular death and heart attacks in patients with stable coronary disease which includes patients with angina and or a previous heart attack, according to results from the landmark EUROPA study1 (EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease), announced today at the European Society of Cardiology (ESC) annual meeting. EUROPA is the largest study ever conducted in patients with stable coronary disease. The study involved 12 218 ..
     
  7. Title: Cipla Medpro addresses the link between homocysteine and cardiovascular risk : drug trends in cardiology
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.280
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... A novel folic acid food supplement containing promethylation agents and anti-oxidants has been launched by Cipla Medpro for patients who experience difficulty in adhering to the lifestyle modifications required for the prevention of both primary and secondary coronary artery disease. Targeting both the South African and International markets, Cipla Medpro has formed a new lifetstyle product division, Gardian Cipla to encourage healthy lifestyles such as quitting smoking, reducing stress, encouraging moderate exercise, healthy eating and weight control, as well as promoting regular check-ups. Interest in the association between homocysteine serum levels and ischaemic heart disease, deep vein thrombosis and pulmonary embolism ..
     
  8. Title: Evidence for use of low molecular weight heparin (Clexane) in STEMI : drug trends in cardiology
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.282
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 282 The use of enoxaparin (Clexane) as a better choice than unfractionated heparin in non-ST-segment acute coronary syndromes has been well established by expert consensus.1 Recent results of HART-II, ASSENT-3, AMISK, Baird et al., and ENTIRE-TIMI 23 are building a picture of growing evidence for using enoxaparin as a better choice, also in ST-segment elevation acute myocardial infarction (STEMI). A recent meta-analysis collected this data and evaluated benefit and risk.2 The analysis included a total of 6 069 patients, 1 108 of them treated with streptokinase (SK), 400 with t-PA, and 4 561 with tenecteplase. The rates of acute myocardial infarction ..
     
  9. Title: ACTION results of nifedipine in stable angina due next year : drug trends in cardiology
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.283
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 283 ACTION is the first randomised, controlled, clinical trial to assess the effects of an anti-anginal drug - nifedipine gastrointestinal therapeutic system (nifedipine GITS) - on cardiovascular event-free survival in chronic, stable angina. The trial is ongoing; 7 700 patients have been entered into the study and results will be published in 2004, after 40 000 patient-years of follow-up. It is clearly a pivotal study in cardiovascular disease (CVD) risk management, because it will have a major impact on future therapy. Prof Poole-Wilson, chief investigator and head of the Department of Cardiac Medicine at the Imperial College in London, noted that ..
     
  10. Title: CHARM shows benefits of Atacand(R) for symptomatic heart failure : drug trends in cardiology
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.284
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 284 Atacand(r) (candesartan cilexetil) an angiotensin receptor blocker (ARB) is proven to reduce cardiovascular death and hospitalisation in chronic heart failure when given together with conventional therapy. AstraZeneca presented data at the European Society of Cardiology (ESC, Vienna, August 2003) annual meeting demonstrating candesartan cilexetil to reduce both cardiovascular deaths as well as hospital admissions for heart failure across a broad spectrum of patients with chronic heart failure. Importantly, candesartan cilexetil is the first angiotensin receptor blocker (ARB) to increase survival in chronic heart failure patients with left ventricular dysfunction, whether or not they are taking an ACE inhibitor. The CHARM ..
     
  11. Title: Rosuvastatin receives FDA approval : drug trends in cardiology
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.286
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 286 AstraZeneca has announced that its new cholesterol-lowering medication, rosuvastatin calcium, which has been shown to lower LDL cholesterol by up to 63%, has received approval from the US Food and Drug Administration (FDA) as an adjunct to diet for the treatment of various lipid disorders, including primary hypercholesterolaemia, mixed dyslipidaemia and isolated hypertriglyceridaemia. This follows the successful advisory committee meeting held in the US in July 2003, where the committee voted unanimously to recommend the approval of rosuvastatin. Rosuvastatin is the newest member of the cholesterol-lowering statin class (HMG-CoA reductase inhibitors) of drug therapy. In addition to its LDL (low-density ..
     
  12. Title: Cardio news
    From: Cardiovascular Journal of South Africa, Vol 14, Issue 5, Sep / Oct
    Published: 2003
    Pages: p.288
    Full text: Click here to order
    Full text: Click here to read online (Login Required)
    Abstract: Extracted from text ... 288 Unsurpassed glycaemic control made simple The Pharmaceutical Division of Merck (Pty) Ltd, marketers of the most prescribed oral anti-diabetic agent, Glucophage, proudly announces the launch of the first fixed-combination drug therapy for unsurpassed glycaemic control - Glucovance(r). Glucovance(r) is a new treatment for improving blood glucose control for patients with type 2 diabetes who are inadequately controlled by existing oral treatments. Glucovance(r) offers unsurpassed glycaemic control in a single tablet. Glucovance(r), the first fixed-combination drug therapy for glycaemic control, brings together two tried and tested ingredients, metformin and glibenclamide, in one tablet.
The role of C-reactive protein:albumin ratio and neutrophil:lymphocyte ratio in predicting coronary artery disease

Published: 26 March 2024
 
Evaluation of cardiac function in paediatric Wilson’s disease patients with advanced echocardiographic modalities (strain and strain rate echocardiography)

Published: 26 March 2024
 
Comprehensive ABC (HbA1c, blood pressure, LDL-C) control and cardiovascular disease risk in patients with type 2 diabetes mellitus and major depressive disorder in a South African managed healthcare organisation

Published: 25 March 2024
 
The predictive value of triglyceride–glucose index for assessing the severity and MACE of premature coronary artery disease

Published: 21 February 2024
 
Obesity is associated with long-term outcome of catheter ablation of atrial fibrillation in patients with dilated cardiomyopathy

Published: 20 February 2024
 
Successful surgical treatment of left ventricular free wall rupture

Published: 19 February 2024
 
Correlation of osteopontin hormone with TIMI score and cardiac markers in patients with acute coronary syndrome presenting with chest pain

Published: 16 February 2024
 
Delayed diagnosis of cardiac amyloidosis in a West African octogenarian

Published: 12 February 2024
 
Impact of COVID-19 on cardiac surgery outcomes

Published: 12 February 2024
 
Percutaneous coronary intervention facilities in Nigeria

Published: 12 February 2024
 
Association of ratios of monocyte/high-density lipoprotein cholesterol and neutrophil/high-density lipoprotein cholesterol with atherosclerotic plaque type on coronary computed tomography

Published: 26 January 2024
 
Assessment of Tp–Te interval in patients with cardiac AL amyloidosis

Published: 15 January 2024
 
Association between Pfizer-BioNTech mRNA vaccine and myocardial infarction: clinical and angiographic insights

Published: 13 December 2023
 
Investigation of the effects of ellagic, vanillic and rosmarinic acid on reperfusion-induced renal injury

Published: 29 November 2023
 
A novel method that can be used in both the diagnosis and treatment of peripheral arterial disease in diabetics: vibration-mediated dilation

Published: 29 November 2023
 
Predictive values of stress hyperglycaemia and glycosylated haemoglobin on admission for long-term recovery of cardiac function in patients with acute myocardial infarction after primary percutaneous coronary intervention

Published: 22 November 2023
 
The relationship between epicardial adipose tissue and choroidal vascularity index in patients with hypertension

Published: 20 November 2023
 
Improving cardiac function of angiotensin receptor/neprilysin inhibitor in patients with acute myocardial infarction: a systematic review and meta-analysis

Published: 17 November 2023
 
Ultrasonographic assessment and clinical outcomes after deployment of a suture-mediated femoral vascular closure device

Published: 16 November 2023
 
Correlation between carotid intima–media thickness and patient outcomes in coronary artery disease in central South Africa

Published: 16 November 2023
 
Contemporary risk factors associated with ischaemic heart disease in central South Africa: a single-centre study

Published: 06 November 2023
 
Comparison of early postoperative results in patients with and without diabetes with low ejection fraction and normal serum creatinine values who underwent coronary artery bypass operation

Published: 27 October 2023
 
Coronary artery bypass grafting in a patient with situs inversus totalis

Published: 20 October 2023
 
Correlation between maternally expressed gene 3 expression and heart rate variability in heart failure patients with ventricular arrhythmia

Published: 06 October 2023
 
A novel U-shaped relationship between serum klotho and abdominal aortic calcification in the general population

Published: 05 October 2023
 
Echocardiographic multiparameter assessment for patients with heart failure with preserved ejection fraction and atrial fibrillation

Published: 04 October 2023
 
Relationship between adiponectin and copeptin levels with long-term cardiovascular mortality in ST-segment elevation myocardial infarction after percutaneous coronary intervention

Published: 04 October 2023
 
Six months of resistance training improves heart rate variability in the elderly

Published: 27 September 2023
 
Association between serum α-klotho level and the prevalence of heart failure in the general population

Published: 27 September 2023
 
The assessment of thoracal approaches in the treatment of aortic coarctation

Published: 15 September 2023
 
Point-of-care testing compared to gold-standard laboratory methods in the measurement of serum lipids

Published: 31 August 2023
 
Outcomes of single-ventricle physiology in central South Africa

Published: 25 August 2023
 
Comparison of serum lipoprotein(a) levels in young and middle-aged patients presenting for the first time with ST-elevation myocardial infarction: a single-centre study

Published: 25 August 2023
 
The value of measured partial oxygen pressure during pulmonary vein closure and the relationship with the diameter of the closed vein in patients with cryoablation

Published: 17 August 2023
 
Paying more attention to arterial hypertension, dyslipidaemia, women and the rural environment in our ongoing fight against cardiovascular diseases and their risk factors

Published: 17 August 2023
 
The relationship between serum osteoprotegerin levels and right atrial and ventricular speckle-tracking measurements in essential hypertension patients with normal left ventricular systolic function

Published: 27 July 2023
 
The association between CHA2DS2-VASc score and aortic valve sclerosis

Published: 26 July 2023
 
Oxidative metabolism of neutrophils in acute coronary syndrome

Published: 25 July 2023
 
Yield of family screening in dilated cardiomyopathy within low-income setting: Tanzanian experience

Published: 25 July 2023
 
Study of the mechanism of Shexiang Baoxin pill-mediated angiogenesis in acute myocardial infarction

Published: 04 July 2023
 
Effects of intravenous sodium thiosulfate on vascular calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis

Published: 03 July 2023
 
Right ventricular function in treatment-naïve human immunodeficiency virus-infected patients

Published: 03 July 2023
 
Changes in blood pressure after catheter-based renal denervation in South Africa

Published: 28 June 2023
 
Effect of insulin resistance on left ventricular remodelling in essential hypertensives: a cross-sectional study

Published: 21 June 2023
 
Impact of the COVID-19 pandemic on cardiology fellowship training in a sub-Saharan African training centre: an African perspective

Published: 19 June 2023
 
The effects on clinical outcomes of administering medications together or separately in prolonged dual antiplatelet therapy after peripheral revascularisation

Published: 19 June 2023
 
Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication

Published: 07 June 2023
 
Is the transradial approach associated with decreased acute kidney injury following percutaneous coronary intervention in patients not complicated by major bleeding and haemodynamic disturbance?

Published: 05 June 2023
 
Effect of lactate levels on extubation time in coronary artery bypass grafting surgery

Published: 05 June 2023
 
Evaluation of clinical results of esmarch bandage application in giant saphenous vein closure during endovenous glue ablation

Published: 03 June 2023
 
Right atrial strain in a normal adult African population according to age

Published: 02 June 2023
 
Long-term experience of the modified David V re-implantation technique for valve-sparing aortic root replacement

Published: 01 June 2023
 
Pre-eclampsia: does cardiac function differ in HIV-positive and -negative women?

Published: 11 May 2023
 
Systemic immune–inflammation index, and neutrophilto-lymphocyte and platelet-to-lymphocyte ratios can predict clinical outcomes in patients with acute coronary syndrome

Published: 05 May 2023
 
A strategy to improve adherence to guidelinedirected medical therapy (GDMT) and the role of the multidisciplinary team in a heart-failure programme

Published: 05 May 2023
 
Association between apelin-12 and creatine kinase-MB, depending on success of reperfusion in STEMI patients

Published: 05 May 2023
 
Investigation of left ventricular changes according to valve type in patients with surgical replacement due to isolated aortic stenosis

Published: 05 May 2023
 
Assessment value of the modified early warning score for long-term prognosis of older patients with chronic heart failure

Published: 28 April 2023
 
A cross-sectional study of the spectrum, aetiology and clinical characteristics of adult mitral valve disease at Chris Hani Baragwanath Academic Hospital

Published: 26 April 2023
 
Identification and treatment of asymptomatic central venous catheter thrombosis after TAVI

Published: 24 April 2023
 
Surgical experience in adults with Ebstein’s anomaly: long-term results

Published: 24 March 2023
 
Effect of different priming fluids on extravascular lung water, cell integrity and oxidative stress in cardiopulmonary bypass surgery

Published: 06 March 2023
 
Calcified right ventricular fibroma in an adult

Published: 03 March 2023
 
Arterial stiffness assessment in obese black South African patients

Published: 13 February 2023
 
Clinical characteristics, diagnostic methods and results of surgically treated histologically benign cardiac myxomas

Published:07 February 2023
 
Characteristics and immediate outcomes of patients who underwent percutaneous balloon mitral valvuloplasty at the Jakaya Kikwete Cardiac Institute, Tanzania

Published:06 February 2023
 
Click here for more information on our Online First Publication Service »
ABOUT CVJA

Editorial Board
CVJA Info
Contact Us
JOURNAL ARTICLES

Current Issue
Online First Articles
Journal Archive
Older Journal Archive
For the Patient
SERVICES

Log onto Sabinet
Submit Manuscript
Register for Editors’ Choice
Copyright Clearance
Why Should I Publish?
INFORMATION

Instructions for Authors
Submit Manuscript
Advertising Rates Card
Reviewers Information
MEDIA RESOURCES

Read Journal Online
Chronic Heart Failure Guide
Video Archive
Follow us on Twitter
All Rights Reserved 2023 © Clinics Cardive Publishing (Pty) Ltd.
The content on this website is intended for healthcare professionals unless stated otherwise.

Advertisements on this website do not constitute a guarantee or endorsement by the journal or publisher of the quality or value
of such products or of the claims made for it by its manufacturer.

Website Development by Design Connection.